These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Facilitation of reentry by lidocaine in canine myocardial infarction. Fazekas T, Scherlag BJ, Mabo P, Patterson E, Lazzara R. Am Heart J; 1994 Feb; 127(2):345-52. PubMed ID: 7507635 [Abstract] [Full Text] [Related]
7. Electropharmacology of the bradycardic agents alinidine and zatebradine (UL-FS 49) in a conscious canine ventricular arrhythmia model of permanent coronary artery occlusion. Aidonidis I, Brachmann J, Rizos I, Zacharoulis A, Stavridis I, Toutouzas P, Kübler W. Cardiovasc Drugs Ther; 1995 Aug; 9(4):555-63. PubMed ID: 8547205 [Abstract] [Full Text] [Related]
11. Provocation of supraventricular tachycardias by an intravenous class I antiarrhythmic drug. Brembilla-Perrot B, Terrier de la Chaise A. Int J Cardiol; 1992 Feb; 34(2):189-98. PubMed ID: 1737670 [Abstract] [Full Text] [Related]
14. Beta receptor blockade potentiates the antiarrhythmic actions of d-sotalol on reentrant ventricular tachycardia in a canine model of myocardial infarction. Kassotis J, Sauberman RB, Cabo C, Wit AL, Coromilas J. J Cardiovasc Electrophysiol; 2003 Nov; 14(11):1233-44. PubMed ID: 14678141 [Abstract] [Full Text] [Related]
15. Electrophysiologic effects of E-4031, a class III antiarrhythmic agent, on re-entrant ventricular arrhythmias in a canine 7-day-old myocardial infarction model. Katoh H, Ogawa S, Furuno I, Sato Y, Yoh S, Saeki K, Nakamura Y. J Pharmacol Exp Ther; 1990 Jun; 253(3):1077-82. PubMed ID: 2359016 [Abstract] [Full Text] [Related]
18. The antifibrillatory actions of UK-68,798, a class III antiarrhythmic agent. Black SC, Chi LG, Mu DX, Lucchesi BR. J Pharmacol Exp Ther; 1991 Aug; 258(2):416-23. PubMed ID: 1865349 [Abstract] [Full Text] [Related]